Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders

Summary We describe two cases of autoimmune thrombocytopenia precipitated by fludarabine therapy in patients with chronic lymphatic leukaemia. Both were treated with high dose steroids and initially responded with recovery of normal platelet counts. One patient developed recurrent autoimmune thrombo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and laboratory haematology 2000-06, Vol.22 (3), p.175-178
Hauptverfasser: Leach, M., Parsons, R.M., Reilly, J.T., Winfield, D.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 178
container_issue 3
container_start_page 175
container_title Clinical and laboratory haematology
container_volume 22
creator Leach, M.
Parsons, R.M.
Reilly, J.T.
Winfield, D.A.
description Summary We describe two cases of autoimmune thrombocytopenia precipitated by fludarabine therapy in patients with chronic lymphatic leukaemia. Both were treated with high dose steroids and initially responded with recovery of normal platelet counts. One patient developed recurrent autoimmune thrombocytopenia on two occasions following re‐exposure to the drug when his disease had become refractory to all other treatments. A retrospective review of the case notes of 45 patients with lymphoproliferative disorders treated with fludarabine over the past 6 years indicated the development of autoimmune thrombocytopenia in 4.5% (two out of 45) and autoimmune haemolytic anaemia in 6.7% (three of the 45).
doi_str_mv 10.1046/j.1365-2257.2000.00305.x
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_10931169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IJLH305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3835-341f61f9cd5e47bac897e62f17f08b998a5dd1534e0089627d3df6c3916574f73</originalsourceid><addsrcrecordid>eNpNkF1L5DAUhoMoOqv7FyQX3rabNF-N4MUgrroMCn4g7E1I84EZ26aknXX67-04rnp1Duc874HzAAAxyjGi_Ncyx4SzrCiYyAuEUI4QQSxf74DZ52IXzBCmOJMlowfgR98vEcIEC7EPDjCSBGMuZ8DMV0MMTbNqHRyeU2yqaMYhdq4N-hTOoYlNVwejhxBbGD309crqpKvwzrukuxGGFtZj0z3HLsU6-Gk4hH8O2tDHZF3qj8Ce13Xvfn7UQ_D4--Lh_Cpb3F5en88XmSElYRmh2HPspbHMUVFpU0rheOGx8KispCw1sxYzQh1CpeSFsMR6bojEnAnqBTkEx9u73apqnFVdCo1Oo_r_7QScfAC6N7r2Sbcm9F8cLQQp2ISdbbHXULvx2xm1ka-WauNYbRyrjXz1Ll-t1fWfxdXUTflsmw_94NafeZ1eFBdEMPV0c6n-4vs7RO6oWpA3vgyIZw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Leach, M. ; Parsons, R.M. ; Reilly, J.T. ; Winfield, D.A.</creator><creatorcontrib>Leach, M. ; Parsons, R.M. ; Reilly, J.T. ; Winfield, D.A.</creatorcontrib><description>Summary We describe two cases of autoimmune thrombocytopenia precipitated by fludarabine therapy in patients with chronic lymphatic leukaemia. Both were treated with high dose steroids and initially responded with recovery of normal platelet counts. One patient developed recurrent autoimmune thrombocytopenia on two occasions following re‐exposure to the drug when his disease had become refractory to all other treatments. A retrospective review of the case notes of 45 patients with lymphoproliferative disorders treated with fludarabine over the past 6 years indicated the development of autoimmune thrombocytopenia in 4.5% (two out of 45) and autoimmune haemolytic anaemia in 6.7% (three of the 45).</description><identifier>ISSN: 0141-9854</identifier><identifier>EISSN: 1365-2257</identifier><identifier>DOI: 10.1046/j.1365-2257.2000.00305.x</identifier><identifier>PMID: 10931169</identifier><identifier>CODEN: CLHAD3</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adult ; Aged ; Anemia, Hemolytic - chemically induced ; Antineoplastic Agents - adverse effects ; Antineoplastic Agents - therapeutic use ; Autoimmune thrombocytopenia ; Biological and medical sciences ; Drug toxicity and drugs side effects treatment ; fludarbine ; Humans ; Immunosuppressive Agents - adverse effects ; Immunosuppressive Agents - therapeutic use ; Leukemia, Lymphocytic, Chronic, B-Cell - complications ; Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy ; lymphoproliferative disorders ; Lymphoproliferative Disorders - complications ; Lymphoproliferative Disorders - drug therapy ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Purpura, Thrombocytopenic, Idiopathic - chemically induced ; Toxicity: blood ; Vidarabine - adverse effects ; Vidarabine - analogs &amp; derivatives ; Vidarabine - therapeutic use</subject><ispartof>Clinical and laboratory haematology, 2000-06, Vol.22 (3), p.175-178</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3835-341f61f9cd5e47bac897e62f17f08b998a5dd1534e0089627d3df6c3916574f73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2257.2000.00305.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2257.2000.00305.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1427325$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10931169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leach, M.</creatorcontrib><creatorcontrib>Parsons, R.M.</creatorcontrib><creatorcontrib>Reilly, J.T.</creatorcontrib><creatorcontrib>Winfield, D.A.</creatorcontrib><title>Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders</title><title>Clinical and laboratory haematology</title><addtitle>Clin Lab Haematol</addtitle><description>Summary We describe two cases of autoimmune thrombocytopenia precipitated by fludarabine therapy in patients with chronic lymphatic leukaemia. Both were treated with high dose steroids and initially responded with recovery of normal platelet counts. One patient developed recurrent autoimmune thrombocytopenia on two occasions following re‐exposure to the drug when his disease had become refractory to all other treatments. A retrospective review of the case notes of 45 patients with lymphoproliferative disorders treated with fludarabine over the past 6 years indicated the development of autoimmune thrombocytopenia in 4.5% (two out of 45) and autoimmune haemolytic anaemia in 6.7% (three of the 45).</description><subject>Adult</subject><subject>Aged</subject><subject>Anemia, Hemolytic - chemically induced</subject><subject>Antineoplastic Agents - adverse effects</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Autoimmune thrombocytopenia</subject><subject>Biological and medical sciences</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>fludarbine</subject><subject>Humans</subject><subject>Immunosuppressive Agents - adverse effects</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - complications</subject><subject>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</subject><subject>lymphoproliferative disorders</subject><subject>Lymphoproliferative Disorders - complications</subject><subject>Lymphoproliferative Disorders - drug therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Purpura, Thrombocytopenic, Idiopathic - chemically induced</subject><subject>Toxicity: blood</subject><subject>Vidarabine - adverse effects</subject><subject>Vidarabine - analogs &amp; derivatives</subject><subject>Vidarabine - therapeutic use</subject><issn>0141-9854</issn><issn>1365-2257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF1L5DAUhoMoOqv7FyQX3rabNF-N4MUgrroMCn4g7E1I84EZ26aknXX67-04rnp1Duc874HzAAAxyjGi_Ncyx4SzrCiYyAuEUI4QQSxf74DZ52IXzBCmOJMlowfgR98vEcIEC7EPDjCSBGMuZ8DMV0MMTbNqHRyeU2yqaMYhdq4N-hTOoYlNVwejhxBbGD309crqpKvwzrukuxGGFtZj0z3HLsU6-Gk4hH8O2tDHZF3qj8Ce13Xvfn7UQ_D4--Lh_Cpb3F5en88XmSElYRmh2HPspbHMUVFpU0rheOGx8KispCw1sxYzQh1CpeSFsMR6bojEnAnqBTkEx9u73apqnFVdCo1Oo_r_7QScfAC6N7r2Sbcm9F8cLQQp2ISdbbHXULvx2xm1ka-WauNYbRyrjXz1Ll-t1fWfxdXUTflsmw_94NafeZ1eFBdEMPV0c6n-4vs7RO6oWpA3vgyIZw</recordid><startdate>200006</startdate><enddate>200006</enddate><creator>Leach, M.</creator><creator>Parsons, R.M.</creator><creator>Reilly, J.T.</creator><creator>Winfield, D.A.</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200006</creationdate><title>Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders</title><author>Leach, M. ; Parsons, R.M. ; Reilly, J.T. ; Winfield, D.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3835-341f61f9cd5e47bac897e62f17f08b998a5dd1534e0089627d3df6c3916574f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anemia, Hemolytic - chemically induced</topic><topic>Antineoplastic Agents - adverse effects</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Autoimmune thrombocytopenia</topic><topic>Biological and medical sciences</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>fludarbine</topic><topic>Humans</topic><topic>Immunosuppressive Agents - adverse effects</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - complications</topic><topic>Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy</topic><topic>lymphoproliferative disorders</topic><topic>Lymphoproliferative Disorders - complications</topic><topic>Lymphoproliferative Disorders - drug therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Purpura, Thrombocytopenic, Idiopathic - chemically induced</topic><topic>Toxicity: blood</topic><topic>Vidarabine - adverse effects</topic><topic>Vidarabine - analogs &amp; derivatives</topic><topic>Vidarabine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leach, M.</creatorcontrib><creatorcontrib>Parsons, R.M.</creatorcontrib><creatorcontrib>Reilly, J.T.</creatorcontrib><creatorcontrib>Winfield, D.A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Clinical and laboratory haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leach, M.</au><au>Parsons, R.M.</au><au>Reilly, J.T.</au><au>Winfield, D.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders</atitle><jtitle>Clinical and laboratory haematology</jtitle><addtitle>Clin Lab Haematol</addtitle><date>2000-06</date><risdate>2000</risdate><volume>22</volume><issue>3</issue><spage>175</spage><epage>178</epage><pages>175-178</pages><issn>0141-9854</issn><eissn>1365-2257</eissn><coden>CLHAD3</coden><abstract>Summary We describe two cases of autoimmune thrombocytopenia precipitated by fludarabine therapy in patients with chronic lymphatic leukaemia. Both were treated with high dose steroids and initially responded with recovery of normal platelet counts. One patient developed recurrent autoimmune thrombocytopenia on two occasions following re‐exposure to the drug when his disease had become refractory to all other treatments. A retrospective review of the case notes of 45 patients with lymphoproliferative disorders treated with fludarabine over the past 6 years indicated the development of autoimmune thrombocytopenia in 4.5% (two out of 45) and autoimmune haemolytic anaemia in 6.7% (three of the 45).</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>10931169</pmid><doi>10.1046/j.1365-2257.2000.00305.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0141-9854
ispartof Clinical and laboratory haematology, 2000-06, Vol.22 (3), p.175-178
issn 0141-9854
1365-2257
language eng
recordid cdi_pubmed_primary_10931169
source MEDLINE; Access via Wiley Online Library
subjects Adult
Aged
Anemia, Hemolytic - chemically induced
Antineoplastic Agents - adverse effects
Antineoplastic Agents - therapeutic use
Autoimmune thrombocytopenia
Biological and medical sciences
Drug toxicity and drugs side effects treatment
fludarbine
Humans
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell - complications
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
lymphoproliferative disorders
Lymphoproliferative Disorders - complications
Lymphoproliferative Disorders - drug therapy
Male
Medical sciences
Pharmacology. Drug treatments
Purpura, Thrombocytopenic, Idiopathic - chemically induced
Toxicity: blood
Vidarabine - adverse effects
Vidarabine - analogs & derivatives
Vidarabine - therapeutic use
title Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A57%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20thrombocytopenia:%20A%20complication%20of%20fludarabine%20therapy%20in%20lymphoproliferative%20disorders&rft.jtitle=Clinical%20and%20laboratory%20haematology&rft.au=Leach,%20M.&rft.date=2000-06&rft.volume=22&rft.issue=3&rft.spage=175&rft.epage=178&rft.pages=175-178&rft.issn=0141-9854&rft.eissn=1365-2257&rft.coden=CLHAD3&rft_id=info:doi/10.1046/j.1365-2257.2000.00305.x&rft_dat=%3Cwiley_pubme%3EIJLH305%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10931169&rfr_iscdi=true